ENTRY       D00238                      Drug
NAME        Azathioprine (JP18/USP/INN);
            Azasan (TN);
            Imuran (TN);
            Jayempi (TN)
PRODUCT     IMURAN (Sebela Pharmaceuticals)
  GENERIC   AZASAN (Salix Pharmaceuticals)
            AZATHIOPRINE (American Health Packaging)
            AZATHIOPRINE (Amneal Pharmaceuticals NY LLC)
            AZATHIOPRINE (Aphena Pharma Solutions - Tennessee)
            AZATHIOPRINE (Ascend Laboratories)
            AZATHIOPRINE (AvKARE)
            AZATHIOPRINE (AvKARE)
            AZATHIOPRINE (Glenmark Pharmaceuticals)
            AZATHIOPRINE (Golden State Medical Supply)
            AZATHIOPRINE (Oceanside Pharmaceuticals)
            AZATHIOPRINE (PD-Rx Pharmaceuticals)
            AZATHIOPRINE (REMEDYREPACK)
            AZATHIOPRINE (Zydus Lifesciences Limited)
            AZATHIOPRINE (Zydus Lifesciences Limited)
            AZATHIOPRINE (Zydus Pharmaceuticals USA)
            AZATHIOPRINE (Zydus Pharmaceuticals USA)
FORMULA     C9H7N7O2S
EXACT_MASS  277.0382
MOL_WEIGHT  277.2626
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
REMARK      Same as: C06837
            Therapeutic category: 3999
            ATC code: L04AX01
            Chemical structure group: DG00743
            Product (DG00743): D00238<JP/US> D03033<US>
EFFICACY    Immunosuppressant, Nucleic acid biosynthesis inhibitor
  DISEASE   Prevention of rejection in renal homotransplantation [DS:H00083]
            Rheumatoid arthritis [DS:H00630]
COMMENT     Azathioprine is metabolized to 6-mercaptopurine (6-MP) [DR:D04931]
INTERACTION  
STR_MAP     map07046  Immunosuppressive agents
            map07050  Antirheumatics - DMARDs and biological agents
OTHER_MAP   map00983  Drug metabolism - other enzymes
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AX Other immunosuppressants
                 L04AX01 Azathioprine
                  D00238  Azathioprine (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Azathioprine
                D00238  Azathioprine (JP18/USP/INN)
             Immunological Agents
              Immunosuppressants
               Antimetabolites, Purine
                Azathioprine
                 D00238  Azathioprine (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D00238  Azathioprine (JP18/USP/INN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG00743  Azathioprine
                D00238  Azathioprine
            Drug classes [BR:br08332]
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D00238  Azathioprine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00238  Azathioprine
              D00238  Azathioprine tablets
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00238
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00238
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG00743  Azathioprine
DBLINKS     CAS: 446-86-6
            PubChem: 7847305
            ChEBI: 2948
            LigandBox: D00238
            NIKKAJI: J2.047H
ATOM        19
            1   C8y C    22.2600  -23.0300
            2   C8y C    21.0700  -23.7300
            3   S2a S    22.2600  -21.6300
            4   N5x N    23.4500  -23.7300
            5   C8y C    21.0700  -25.1300
            6   N4x N    19.7400  -23.2400
            7   C8y C    21.0700  -20.9300
            8   C8x C    23.4500  -25.1300
            9   N5x N    19.7400  -25.5500
            10  N5x N    22.2600  -25.8300
            11  C8x C    18.9000  -24.4300
            12  C8y C    21.0700  -19.5300
            13  O3a O    23.5200  -19.5300 #-
            14  N2b N    22.2600  -18.8300 #+
            15  N5x N    19.7400  -19.1100
            16  C8x C    18.9000  -20.2300
            17  N4y N    19.7400  -21.3500
            18  O3a O    22.2600  -17.4300
            19  C1a C    18.5276  -22.0500
BOND        21
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 1
            10    6  11 1
            11    8  10 2
            12    9  11 2
            13    7  12 2
            14   13  14 1
            15   12  14 1
            16   12  15 1
            17   15  16 2
            18   16  17 1
            19    7  17 1
            20   14  18 2
            21   17  19 1
///
